USPTO serial 79350443
JYSINCT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 21, 2023
- Examiner
- HSU, FONG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with JYSINCT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | ACTIVE | — |
| 010 | Medical and surgical apparatus and instruments for diagnosing and treating cardiovascular diseases; medical and surgical apparatus and instruments for diagnosing and treating dermatological diseases; medical and surgical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical and surgical apparatus and instruments for diagnosing and treating central nervous system diseases; medical and surgical apparatus and instruments for diagnosing and treating gastro-intestinal diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical and surgical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical and surgical apparatus and instruments for use in urology; medical and surgical apparatus and instruments for ophthalmological use; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical and surgical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical and surgical apparatus and instruments for diagnostic radiopharmaceutical use; medical and surgical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical and surgical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical and surgical apparatus and instruments for introducing pharmaceutical preparations into the human body | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 30, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 6, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 6, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 23, 2023 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Feb 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 7, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 7, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 7, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 7, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 22, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |